Cargando…
Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonists
A series of nitrogen heterocycles containing α–ethoxyphenylpropionic acid derivatives were designed as dual PPARα/γ agonist ligands for the treatment of type 2 diabetes (T2D) and its complications. 6-Benzoyl-benzothiazol-2-one was the most tolerant of the tested heterocycles in which incorporation o...
Autores principales: | Hurtevent, Aurélie, Le Naour, Morgan, Leclerc, Veronique, Carato, Pascal, Melnyk, Patricia, Hennuyer, Nathalie, Staels, Bart, Beucher-Gaudin, Monique, Caignard, Daniel-Henri, Dacquet, Catherine, Lebegue, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006651/ https://www.ncbi.nlm.nih.gov/pubmed/31939313 http://dx.doi.org/10.1080/14756366.2020.1713771 |
Ejemplares similares
-
1-(1,3-Benzothiazol-2-yl)-3-benzoylthiourea
por: Yunus, Uzma, et al.
Publicado: (2007) -
2-(6-Benzoyl-2-oxo-1,3-benzothiazol-3-yl)acetic acid
por: Aydın, Abdullah, et al.
Publicado: (2009) -
Tetrabutylammonium N-benzoyl-6-nitro-1,3-benzothiazol-2-aminide
por: Nguyen, Quynh Pham Bao, et al.
Publicado: (2010) -
Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011) -
Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARα
por: Ratman, Dariusz, et al.
Publicado: (2016)